In situ misemgel as a multifunctional dual-absorption platform for nasal delivery of raloxifene hydrochloride: formulation, characterization, and in vivo performance
Open Access
- 1 October 2018
- journal article
- research article
- Published by Taylor & Francis in International Journal of Nanomedicine
- Vol. ume 13, 6325-6335
Abstract
Background: Raloxifene hydrochloride (RLX) is approved by the US Food and Drug Administration for the treatment and prevention of osteoporosis, in addition to reducing the risk of breast cancer in postmenopausal women. RLX has the disadvantages of low aqueous solubility, extensive presystemic intestinal glucuronidation, and first-pass metabolism, resulting in a limited bioavailability of only 2%. The aim of this work was to enhance the bioavailability of RLX via the formulation of an in situ nasal matrix (misemgel) comprising micelles made of vitamin E and D-α-tocopheryl polyethylene glycol 1000 succinate and nanosized self-emulsifying systems (NSEMS). Materials and methods: Optimization of the RLX-loaded NSEMS was performed using a mixture design. The formulations were characterized by particle size and then incorporated into an in situ nasal gel. Transmission electron microscopy, bovine nasal mucosa ex vivo permeation, and visualization using a fluorescence laser microscope were carried out on the RLX in situ misemgel comparing with raw RLX in situ gel. In addition, the in vivo performance was studied in rats. Results: The results revealed improved permeation parameters for RLX misemgel compared with control gel, with an enhancement factor of 2.4. In vivo studies revealed a 4.79- and 13.42-fold increased bioavailability for RLX in situ misemgel compared with control RLX in situ gel and commercially available tablets, respectively. The obtained results highlighted the efficacy of combining two different formulations to enhance drug delivery and the benefits of utilizing different possible paths for drug absorption. Conclusion: The developed in situ misemgel matrix could be considered as a promising multifunctional platform for nasal delivery which works based on a dual-absorption mechanism.Keywords
This publication has 44 references indexed in Scilit:
- Formulation and In Vitro Evaluation of Salbutamol Sulphate In Situ Gelling Nasal InsertsAAPS PharmSciTech, 2013
- Nanoemulsion liquid preconcentrates for raloxifene hydrochloride: optimization and in vivo appraisalInternational Journal of Nanomedicine, 2012
- Use of tamoxifen and raloxifene for breast cancer chemoprevention in 2010Breast Cancer Research and Treatment, 2012
- Impact of Intestinal Glucuronidation on the Pharmacokinetics of RaloxifeneDrug Metabolism and Disposition, 2011
- SNEDDS containing bioenhancers for improvement of dissolution and oral absorption of lacidipine. I: Development and optimizationInternational Journal of Pharmaceutics, 2010
- Optimization and in situ intestinal absorption of self-microemulsifying drug delivery system of oridoninInternational Journal of Pharmaceutics, 2008
- Lipid excipients and delivery systems for pharmaceutical development: A regulatory perspectiveAdvanced Drug Delivery Reviews, 2008
- Development and bioadhesive properties of chitosan-ethylcellulose microspheres for nasal deliveryInternational Journal of Pharmaceutics, 2005
- Ion-Activated In Situ Gelling Systems for Sustained Ophthalmic Delivery of Ciprofloxacin HydrochlorideDrug Delivery, 2003
- Influence of Peroxide Impurities in Povidone and Crospovidone on the Stability of Raloxifene Hydrochloride in Tablets: Identification and Control of an Oxidative Degradation ProductPharmaceutical Development and Technology, 2000